5.2 Proliferative & Remodeling Phases

Key Takeaways

  • The proliferative phase spans approximately days 4 to 21 post-injury and is characterized by angiogenesis, fibroplasia, extracellular matrix deposition, granulation tissue formation, and epithelialization.
  • Angiogenesis is primarily driven by Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (bFGF) in response to local tissue hypoxia, sprouting new capillaries into the wound bed.
  • Epithelialization occurs via keratinocyte migration from intact wound margins and skin appendages (hair follicles, sebaceous glands), migrating over a moist vascularized bed until contact inhibition occurs.
  • The remodeling and maturation phase begins around day 21 and can persist for 1 to 2 years, replacing immature Type III collagen with mature, cross-linked Type I collagen.
  • Scar tissue never achieves the tensile strength of original intact skin; maximum tensile strength reaches approximately 80% at 3 to 3 months post-injury.
Last updated: July 2026

Proliferative & Remodeling Phases

Once the wound bed is cleared of microbial pathogens and cellular debris by neutrophils and M1 macrophages, tissue repair advances into the anabolic reconstruction phases: the Proliferative Phase (spanning approximately Days 4 to 21) and the Remodeling / Maturation Phase (beginning around Day 21 and continuing for up to 1 to 2 years). Understanding these advanced stages is crucial for wound specialists managing tissue deficits, structural repairs, and scar dynamics.


1. Phase 3: The Proliferative Phase (Days 4 to 21)

The primary hallmark of the proliferative phase is the replacement of the temporary fibrin-fibronectin provisional clot with viable, vascularized granulation tissue and the restoration of a continuous epidermal barrier. The proliferative phase encompasses four concurrent sub-processes: Angiogenesis, Fibroplasia / Matrix Synthesis, Granulation Tissue Formation, and Epithelialization.

                  PROLIFERATIVE PHASE DYNAMICS (Days 4 - 21)
┌──────────────────────────────────────────────────────────────────────────┐
│ 1. Angiogenesis (VEGF & bFGF drive endothelial sprouting under hypoxia)  │
│ 2. Fibroplasia (PDGF & TGF-β stimulate fibroblast synthesis of Type III) │
│ 3. Granulation Tissue (Beefy red matrix of capillaries, collagen & ECM) │
│ 4. Epithelialization (Keratinocyte migration guided by EGF & KGF)       │
└──────────────────────────────────────────────────────────────────────────┘

Angiogenesis (Neovascularization)

Tissue disruption creates a profoundly hypoxic environment at the wound center (PO₂ often < 10-15 mmHg). Hypoxia stabilizes Hypoxia-Inducible Factor 1-alpha (HIF-1α), which translocates to the nucleus and upregulates the gene expression of Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (bFGF).

Angiogenesis follows a highly organized sequential sequence:

  1. Endothelial Activation: VEGF binds to VEGFR-2 on local intact venular endothelial cells.
  2. Matrix Degradation: Endothelial cells release Matrix Metalloproteinases (MMPs) to break down the basement membrane of parent blood vessels.
  3. Migration & Proliferation: Specialized "tip cells" extend filopodia and migrate toward the VEGF gradient, followed by proliferating "stalk cells" that form a hollow vascular tube (lumen).
  4. Vascular Maturation: Angiopoietin-1 (Ang-1) and Platelet-Derived Growth Factor-BB (PDGF-BB) recruit pericytes and smooth muscle cells to stabilize the newly formed capillary loops.

Fibroplasia and Collagen Synthesis

Driven by PDGF, TGF-β1, and FGF, dermal fibroblasts migrate into the wound space using the provisional fibrin matrix as a scaffold. Once resident, fibroblasts shift into active synthetic mode:

  • Collagen Deposition: Fibroblasts synthesize and secrete procollagen chains, which are processed extracellularly into tropocollagen and assemble into collagen fibrils. The predominant early form synthesized during proliferation is Type III collagen (a thin, unorganized isoform).
  • Ground Substance: Fibroblasts simultaneously deposit non-collagenous ECM components, including fibronectin, hyaluronic acid, and proteoglycans (sulfated glycosaminoglycans).

Granulation Tissue Characteristics

Healthy granulation tissue represents the golden clinical benchmark of proliferative success. Clinically, it presents as:

  • Color: Vivid, beefy red due to dense capillary loops.
  • Texture: Soft, granular, and moist.
  • Function: Fills tissue voids, provides resistance to infection, and acts as a supportive substrate over which epithelial cells can migrate.

CWS Clinical Alert: Pale, friable, dark red, or exuberant (hypergranulation) tissue indicates pathology—such as severe tissue ischemia, local bacterial infection/biofilm, or mechanical irritation—requiring targeted clinical intervention before epithelialization can proceed.

Epithelialization

Epithelialization is the process of restoring epidermal integrity across the open wound surface. Keratinocytes originate from two primary sources:

  1. Wound Margins: Intact basal keratinocytes at the wound edges.
  2. Dermal Appendages: Epithelial stem cell reservoirs located in hair follicles, sebaceous glands, and eccrine sweat glands (crucial for partial-thickness wound rapid re-epithelialization).

Keratinocyte Migration Mechanics

  • Phenotypic Alteration: Keratinocytes dissolve their hemidesmosomal attachments to the basement membrane, retract intracellular tonofilaments, and express integrin receptors (such as αvβ5 and αvβ6) that allow adhesion to fibronectin and vitronectin.
  • Leap-Frog vs. Tractor-Tread Migration: Keratinocytes migrate across the wound bed using lamellipodia. They require a moist, viable, vascularized surface; if a dry eschar is present, keratinocytes must secrete collagenases to dissect underneath the non-viable tissue, significantly delaying closure.
  • Humoral Signals: Migration and proliferation are driven by Epidermal Growth Factor (EGF), Transforming Growth Factor-alpha (TGF-α), and Keratinocyte Growth Factor (KGF / FGF-7).
  • Contact Inhibition: When migrating sheets of keratinocytes from opposing wound edges meet, physical contact triggers contact inhibition, halting horizontal cell movement. Keratinocytes then differentiate vertically, forming the stratified epidermal layers and synthesizing a new basement membrane composed of Type IV collagen and laminin.

2. Phase 4: Remodeling & Maturation Phase (Day 21 to 1-2 Years)

Once the epithelial surface is restored and the wound space is filled, the wound enters the prolonged Remodeling and Maturation Phase. The primary goals of this phase are to increase tissue tensile strength, reorganize extracellular matrix architecture, and reduce scar bulk and vascularity.

Day 21 ───────────────────────────────────────────────────► 1 to 2 Years
Type III Collagen (Immature, thin) ──► Replaced by ──► Type I Collagen (Thick, parallel)
High Vascularity & Cell Density  ──► Apoptosis  ──► Avascular, Acellular Scar
Low Tensile Strength (~20%)       ──► Cross-linking ──► Max Tensile Strength (~80%)

The Collagen Isoform Transition

The defining biochemical event of remodeling is the enzymatic turnover of collagen:

  • Replacement of Type III by Type I Collagen: Immature Type III collagen (which constitutes up to 30% of early granulation tissue) is degraded by specific collagenases (MMP-1, MMP-8) and replaced by robust Type I collagen (the dominant structural collagen of intact dermis).
  • Fibril Realignment: Randomly oriented collagen fibers are broken down and re-deposited along lines of mechanical tension and stress (following Wolff's law of tissue remodeling).
  • Intermolecular Cross-Linking: Lysyl oxidase (a copper-dependent enzyme) catalyzes covalent cross-links between lysine and hydroxylysine residues in collagen molecules, dramatically increasing structural rigidity and shear resistance.

Wound Contraction & Myofibroblasts

Wound contraction reduces the overall surface area of open tissue deficits. Under the influence of TGF-β1 and local mechanical stress, a subset of dermal fibroblasts differentiates into myofibroblasts.

  • Myofibroblasts express alpha-smooth muscle actin (α-SMA) microfilaments anchored to the ECM via fibronexus complexes.
  • As myofibroblasts contract, they pull the surrounding intact tissue margins toward the center of the wound.
  • While beneficial in full-thickness trunk or extremity wounds, excessive contraction over flexor joints can produce debilitating scar contractures.

Scar Maturation & Regression

Over several months, cell density decreases markedly. Excess capillaries undergo regression via endothelial apoptosis, causing the scar to transition from a raised, hyperemic red/purple appearance to a flat, pale, supple scar. Fibroblasts and macrophages also undergo apoptosis, leaving an acellular matrix dominated by collagen Type I.

Tensile Strength Dynamics

It is a crucial principle of wound management that repaired cutaneous scar tissue never regains 100% of the tensile strength of uninjured skin.

  • 1 Week Post-Injury: Approximately 3% of original strength.
  • 3 Weeks Post-Injury: Approximately 20% of original strength (end of proliferative phase).
  • 3 Months Post-Injury: Approximately 70% to 80% of original strength.
  • Maximum Long-Term Strength: Caps at approximately 80% of intact, uninjured skin strength at 1 to 2 years.

3. Comparative Overview of Proliferative vs. Remodeling Phase

Feature / ParameterProliferative PhaseRemodeling / Maturation Phase
TimeframeDays 4 to 21Day 21 up to 1 to 2 years
Primary GoalFill tissue void & restore barrierMaximize tensile strength & structural order
Dominant Cell TypesFibroblasts, endothelial cells, keratinocytesMyofibroblasts (early), acellular matrix (late)
Collagen DominanceType III collagen (immature, randomly oriented)Type I collagen (mature, cross-linked, aligned)
VascularityHigh (hyperemic, dense capillary loops)Low (capillary regression via apoptosis)
Tensile StrengthIncreases from ~3% to ~20%Increases from ~20% to max limit of ~80%
Key Signaling FactorsVEGF, bFGF, PDGF, TGF-β, EGF, KGFLysyl oxidase, MMP-1, MMP-8, TGF-β1

4. Pathological Variations in Remodeling

  • Hypertrophic Scars: Excessive collagen deposition contained within the original boundaries of the wound; often improves spontaneously over time.
  • Keloid Scars: Overgrowth of collagen Type I and III that extends beyond the original wound borders into uninjured surrounding skin; high recurrence rate after surgical excision.
  • Dehiscence: Breakdown of a closed wound due to inadequate collagen synthesis, lack of vitamin C cofactors, or premature mechanical stress before sufficient tensile strength is established.
Test Your Knowledge

A patient asks a wound specialist how strong their healed full-thickness abdominal surgical scar will be compared to their normal uninjured skin at one year post-op. What is the maximum percentage of original tensile strength that scar tissue can achieve?

A
B
C
D
Test Your Knowledge

During the proliferative phase of wound repair, which growth factor acts as the primary stimulator of angiogenesis in response to local tissue hypoxia?

A
B
C
D
Test Your Knowledge

During the maturation phase of tissue repair, which biochemical transition is responsible for significantly increasing the structural integrity and alignment of scar tissue?

A
B
C
D